Tsuchiya K
Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1999 Jan;74(1):41-52.
The present study examined the effect of repeated methamphetamine (MA) pretreatment on conditioned fear stress in male Wistar-King rats. Rats received MA or the vehicle according to the repeated escalating dose schedule (1.25, 2.5, 3.75, 5 mg/kg s.c x2/every other day for a week). After a 5 day drug abstinent period, the rats were exposed to conditioned fear stress (CFS; exposure to an environment paired previously with footshock). Repeated but not single MA pretreatment significantly increased conditioned freezing behavior, suggesting that rats previously exposed to chronic MA are hypersensitive to subsequent stress than control rats. Repeated MA treatment did not decrease basal dopamine concentrations in the brain. Furthermore, repeated co-administration of MK-801 (non-competitive NMDA antagonist), amfonelic acid (dopamine reuptake inhibitor) or fluoxetine (serotonin reuptake inhibitor) with MA did not alter the enhanced freezing behavior. Taken together, it seems that MA-induced hypersensitivity to stress is not due to the neurotoxic effect of MA. While co-administration of SCH23390 (D1/5 antagonist) or raclopride (D2/3 antagonist) had no effect on the MA-induced increase in freezing, co-administration of nemonapride (D2/3/4 antagonist) prevented this increase. These results suggest that MA-induced enhancement of anxiety might be mediated by D4 receptors. The homovanilic acid (HVA) levels in the striatum were elevated by footshock in MA-treated rats but not in saline-treated rats. Furthermore, MA-treated rats showed increased metabolism of dopamine (DA) in the medial prefrontal cortex (mPFC), even when placed in the shock chamber without shocks. The HVA levels in the striatum in MA-treated rats were more elevated by CFS than these in saline-treated rats. These results suggest that the striatum DA system, as well as the mPFC DA system suggested previously, may be associated with emotional hypersensitivity to stress following repeated MA treatment.
本研究检测了重复给予甲基苯丙胺(MA)预处理对雄性Wistar-King大鼠条件性恐惧应激的影响。大鼠按照重复递增剂量方案(1.25、2.5、3.75、5mg/kg皮下注射,每两天一次,共一周)接受MA或溶剂。在5天的药物戒断期后,将大鼠暴露于条件性恐惧应激(CFS;暴露于先前与足部电击配对的环境)。重复而非单次给予MA预处理显著增加了条件性僵住行为,这表明先前暴露于慢性MA的大鼠比对照大鼠对随后的应激更敏感。重复给予MA治疗并未降低大脑中的基础多巴胺浓度。此外,将MK-801(非竞争性NMDA拮抗剂)、安非他明(多巴胺再摄取抑制剂)或氟西汀(5-羟色胺再摄取抑制剂)与MA重复联合给药并未改变增强的僵住行为。综上所述,MA诱导的对应激的超敏反应似乎并非由于MA的神经毒性作用。虽然联合给予SCH23390(D1/5拮抗剂)或雷氯必利(D2/3拮抗剂)对MA诱导的僵住增加没有影响,但联合给予奈莫必利(D2/3/4拮抗剂)可阻止这种增加。这些结果表明,MA诱导的焦虑增强可能由D4受体介导。在接受MA治疗的大鼠中,纹状体中的高香草酸(HVA)水平因足部电击而升高,但在接受生理盐水治疗的大鼠中则未升高。此外,即使将接受MA治疗的大鼠置于无电击的休克室中,它们在内侧前额叶皮质(mPFC)中的多巴胺(DA)代谢也会增加。与接受生理盐水治疗的大鼠相比,接受MA治疗的大鼠纹状体中的HVA水平因CFS而升高得更多。这些结果表明,纹状体多巴胺系统以及先前提出的mPFC多巴胺系统可能与重复给予MA治疗后对应激的情绪超敏反应有关。